Bentham Science Logo

Track Your Manuscript:


Current Drug Targets

Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

Contents

Current Drug Targets, Volume 22 - Number 16


Review Article (Mini-Review)

Combinational Approaches Targeting Neurodegeneration, Oxidative Stress, and Inflammation in the Treatment of Diabetic Retinopathy

, 22(16): 1810 - 1824

Siddhi Dilip Chalke and Pravin Popatrao Kale*


DOI: 10.2174/1389450122666210319113136



Review Article


Review Article

ACE2 as a Key Target for Treatment of COVID-19 Related Cardiovascular Diseases: Current Progress and Prospect

, 22(16): 1832 - 1843

Shuainan Li, Wenya Ma, Fan Yang, Yan Xu, Binbin Xu and Benzhi Cai*


DOI: 10.2174/1389450122666210319110320



Review Article

Recent Progress on Apoptotic Activity of Triazoles

, 22(16): 1844 - 1900

P. Çıkla-Süzgün and Ş.G. Küçükgüzel*


DOI: 10.2174/1389450122666210208181128



Review Article

3D Printing Technology in Pharmaceutical Dosage Forms: Advantages and Challenges

, 22(16): 1901 - 1914

Prasanna Kumar Desu, Balaji Maddiboyina, Kondi Vanitha, Shiva Naga Koteswara Rao Gudhanti, Rapuri Anusha and Vikas Jhawat*


DOI: 10.2174/1389450122666210120142416




Editor-in-Chief

Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.

Advertisement

Dec-2021-ban

Related Journals

Related eBooks

eBooks Catalog